Royal jellies (RJs) possess moisturizing, emulsifying, and stabilizing properties, and a number of pharmacological actions have additionally been discovered to be current, which make them a perfect element for cosmetic and skincare products. Nevertheless, regardless of the considerable efficacies, there’s a lack of research that discover the chemical composition of RJ utilizing metabolome analysis.
Moreover, an analysis of the chemical composition of Indonesian RJs collected from completely different areas has but to be carried out. Due to this fact, the fundamental goal of this examine was to determine any variations in the chemical composition of such RJs. Chemical profiling was additionally carried out to allow extra focused utilization primarily based on the precise compositions.
Chemical profiling can be essential given the wealthy Indonesian biodiversity and the excessive dependence of the RJ compositions on the botanical supply. On this analysis, ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry was used as half of an untargeted metabolomics method.
From the chemical profiling, >30 compounds have been recognized throughout 4 RJ samples. The key constituents of the samples have been discovered to be oligosaccharides, fatty acids, and adenosine monophosphate derivatives. In the meantime, sucrose and planteose have been discovered to be highest in the samples from Banjarnegara and Kediri, whereas dimethyloctanoic acid was discovered to be distinctive to the pattern from Banjarnegara.
It was additionally found that the RJs from Demak and Tuban contained extra natural fatty acids and oligosaccharides than the different samples. Though the pattern from Demak demonstrated good potential for use in the cosmetic, skincare, and bio-supplement industries, the larger abundance of fatty acids and oligosaccharides in the pattern from Tuban indicated that it’s maybe the best suited RJ for use on this discipline.
Information Mining Approaches for Assessing Chemical Coexposures Utilizing Shopper Product Buy Information
The use of shopper products presents a possible for chemical exposures to people. Toxicity testing and publicity fashions are routinely employed to estimate dangers from their use; nevertheless, a key problem is the sparseness of info regarding who makes use of products and which products are used contemporaneously.
Our objective was to display a way to deduce use patterns by method of buy knowledge. We examined buy patterns for three varieties of private care products (cosmetics, hair care, and skincare) and two family care products (family cleaners and laundry provides) utilizing knowledge from 60,000 households collected over a one-year interval in 2012.
The market basket analysis methodology frequent itemset mining (FIM) was used to determine co-occurring units of product purchases for all households and demographic teams primarily based on revenue, training, race/ethnicity, and household composition. Our methodology captured strong co-occurrence patterns for private and family products, globally and for completely different demographic teams.
FIM recognized cosmetic co-occurrence patterns captured in prior surveys of cosmetic use, as properly as a pattern of elevated variety of cosmetic purchases as youngsters mature to teenage years. We suggest that shopper product buy knowledge may be mined to tell person-oriented use patterns for high-throughput chemical screening purposes, for mixture and mixed chemical danger evaluations.
Chemical Elimination of Lead Corrosion Products
Restoration therapy, specimen preparation or mass loss measurements on coupons made of lead require a dependable course of of dissolution of corrosion products. On this examine, a number of varieties of mannequin corrosion products with compositions consultant of these discovered on actual objects have been ready and characterised.
Ten options have been then totally examined in interval cleansing experiments, relating to the effectivity of removing of the corrosion products, corrosivity in the direction of naked lead, and remnants left on the floor. The answer advisable in the present model of the ISO 8470 customary was discovered to be improper for the cleansing of each historic artefacts and corrosion coupons attributable to its incapability to take away sulfide corrosion products and the danger of floor contamination and staining.
An answer of 20% hydrochloric acid is the best option for the preparation of lead coupons earlier than publicity or for analysis of mass loss of uncovered samples as a result of its considerably larger corrosivity in the direction of metallic lead is tolerable for these purposes.
Rochelle salt answer was discovered to be optimum for the cleansing of historic artefacts free of sulfide corrosion products attributable to the lowest corrosivity. None of these various options depart remnants on the floor and they’re environment friendly at laboratory temperature.
Figuring out Risky Chemical Product Tracer Compounds in U.S. Cities
With visitors emissions of risky natural compounds (VOCs) reducing quickly over the final a long time, the contributions of the emissions from different supply classes, such as risky chemical products (VCPs), have turn out to be extra obvious in city air. On this work, in situ measurements of numerous VOCs are reported for New York Metropolis, Pittsburgh, Chicago, and Denver.
The magnitude of completely different emission sources relative to visitors is set by measuring the city enhancement of particular person compounds relative to the enhancement of benzene, a recognized tracer of fossil gas in the United States. The enhancement ratios of a number of VCP compounds to benzene correlate properly with inhabitants density (R2 ∼ 0.6-0.8).
These observations are in keeping with the expectation that some human exercise ought to correlate higher with the inhabitants density than transportation emissions, attributable to the decrease per capita fee of driving in denser cities. Utilizing these knowledge, along with a bottom-up fuel-based stock of car emissions and risky chemical products (FIVE-VCP) stock, we determine tracer compounds for completely different VCP classes: decamethylcyclopentasiloxane (D5-siloxane) for private care products, monoterpenes for fragrances, p-dichlorobenzene for pesticides, D4-siloxane for adhesives, para-chlorobenzotrifluoride (PCBTF) for solvent-based coatings, and Texanol for water-based coatings.
Gemcitabine HCl |
|||
| A1402-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Gemcitabine HCl is an inhibitor of DNA synthesis with the IC50 value of 240.4±29.0 ?M (CCRF-CEM/dCK-/- cells), 14.7±2.8 nM (TC-1 cells), 36.7 ± 5.1 ?M (TC-1-GR cells), and 50 nM (PANC1 cells). |
|||
Fluoxetine HCl |
|||
| A2436-100 | ApexBio | 100 mg | 177.6 EUR |
|
Description: Fluoxetine is a specific presynaptic serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.The serotonin receptor, also known as 5-HT receptor, is a member of G protein-coupled receptorfound in the central and peripheral nervous systems. |
|||
Fluoxetine HCl |
|||
| A2436-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
|
Description: Fluoxetine is a specific presynaptic serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.The serotonin receptor, also known as 5-HT receptor, is a member of G protein-coupled receptorfound in the central and peripheral nervous systems. |
|||
Fluoxetine HCl |
|||
| A2436-500 | ApexBio | 500 mg | 393.6 EUR |
|
Description: Fluoxetine is a specific presynaptic serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.The serotonin receptor, also known as 5-HT receptor, is a member of G protein-coupled receptorfound in the central and peripheral nervous systems. |
|||
Epirubicin HCl |
|||
| A2451-100 | ApexBio | 100 mg | 560.4 EUR |
|
Description: Epirubicin is an inhibitor of DNA topoisomerase (TOPII) [1].Epirubicin belongs to the Anthracylines chemical class, it is a sort of DNA topoisomerase poison. |
|||
Epirubicin HCl |
|||
| A2451-25 | ApexBio | 25 mg | 309.6 EUR |
|
Description: Epirubicin is an inhibitor of DNA topoisomerase (TOPII) [1].Epirubicin belongs to the Anthracylines chemical class, it is a sort of DNA topoisomerase poison. |
|||
Epirubicin HCl |
|||
| A2451-5 | ApexBio | 5 mg | 122.4 EUR |
|
Description: Epirubicin is an inhibitor of DNA topoisomerase (TOPII) [1].Epirubicin belongs to the Anthracylines chemical class, it is a sort of DNA topoisomerase poison. |
|||
Epirubicin HCl |
|||
| A2451-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 147.6 EUR |
|
Description: Epirubicin is an inhibitor of DNA topoisomerase (TOPII) [1].Epirubicin belongs to the Anthracylines chemical class, it is a sort of DNA topoisomerase poison. |
|||
Idarubicin HCl |
|||
| A2476-100 | ApexBio | 100 mg | 686.4 EUR |
|
Description: Idarubicin is an inhibitor of DNA topoisomerase II [1].Idarubicin is a synthetic anthracycline anticancer drug widely used in the treatment of acute myelogenous leukemia and some other hematological malignancies. |
|||
Idarubicin HCl |
|||
| A2476-25 | ApexBio | 25 mg | 268.8 EUR |
|
Description: Idarubicin is an inhibitor of DNA topoisomerase II [1].Idarubicin is a synthetic anthracycline anticancer drug widely used in the treatment of acute myelogenous leukemia and some other hematological malignancies. |
|||
Idarubicin HCl |
|||
| A2476-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: Idarubicin is an inhibitor of DNA topoisomerase II [1].Idarubicin is a synthetic anthracycline anticancer drug widely used in the treatment of acute myelogenous leukemia and some other hematological malignancies. |
|||
Idarubicin HCl |
|||
| A2476-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
|
Description: Idarubicin is an inhibitor of DNA topoisomerase II [1].Idarubicin is a synthetic anthracycline anticancer drug widely used in the treatment of acute myelogenous leukemia and some other hematological malignancies. |
|||
ADL5859 HCl |
|||
| A2986-100 | ApexBio | 100 mg | 1423.2 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
ADL5859 HCl |
|||
| A2986-25 | ApexBio | 25 mg | 588 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
ADL5859 HCl |
|||
| A2986-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
ADL5859 HCl |
|||
| A2986-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 261.6 EUR |
|
Description: Selective ? opioid receptor agonists are promising potential therapeutic agents for the treatment of various types of pain conditions. A spirocyclic derivative was identified as a promising hit through screening. |
|||
Prazosin HCl |
|||
| A5318-100 | ApexBio | 100 mg | 199.2 EUR |
|
Description: ?1 and ?2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). Also available as part of the ?1-Adrenoceptor Tocriset? and Mixed Adre |
|||
Prazosin HCl |
|||
| A5318-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: ?1 and ?2B-adrenoceptor antagonist. Also a potent antagonist at the melatonin MT3 receptor (Ki = 10.2 nM). Also available as part of the ?1-Adrenoceptor Tocriset? and Mixed Adre |
|||
Moxifloxacin HCl |
|||
| A5323-200 | ApexBio | 200 mg | 268.8 EUR |
|
Description: Moxifloxacin HCl is anti-infective compound with a broad antibacterial spectrum.[1] Moxifloxacin is a fourth generation fluoroquinolone antibacterial agent with a broad antibacterial spectrum against Gram positive bacteria and Gram negative bacteria in vitro. |
|||
Moxifloxacin HCl |
|||
| A5323-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Moxifloxacin HCl is anti-infective compound with a broad antibacterial spectrum.[1] Moxifloxacin is a fourth generation fluoroquinolone antibacterial agent with a broad antibacterial spectrum against Gram positive bacteria and Gram negative bacteria in vitro. |
|||
Moxifloxacin HCl |
|||
| A5323-50 | ApexBio | 50 mg | 129.6 EUR |
|
Description: Moxifloxacin HCl is anti-infective compound with a broad antibacterial spectrum.[1] Moxifloxacin is a fourth generation fluoroquinolone antibacterial agent with a broad antibacterial spectrum against Gram positive bacteria and Gram negative bacteria in vitro. |
|||
Ziprasidone HCl |
|||
| A5350-100 | ApexBio | 100 mg | 199.2 EUR |
|
Description: Atypical antipsychotic that displays combined serotonin and dopamine receptor antagonism. Displays high affinity at 5-HT2A receptors with a 5-HT2A/D2 affinity ratio greater than any other clinically available atypical antipsychotics (pKi values are 9.38, |
|||
Ziprasidone HCl |
|||
| A5350-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 142.8 EUR |
|
Description: Atypical antipsychotic that displays combined serotonin and dopamine receptor antagonism. Displays high affinity at 5-HT2A receptors with a 5-HT2A/D2 affinity ratio greater than any other clinically available atypical antipsychotics (pKi values are 9.38, |
|||
SRT1720 HCl |
|||
| A4180-10 | ApexBio | 10 mg | 309.6 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-200 | ApexBio | 200 mg | 1730.4 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-5 | ApexBio | 5 mg | 212.4 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 226.8 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-50 | ApexBio | 50 mg | 825.6 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
SRT1720 HCl |
|||
| A4180-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. The activity of SRT1720 as a SIRT1 activator is stronger than that of resveratrol. |
|||
Rosiglitazone HCl |
|||
| A4310-100 | ApexBio | 100 mg | 157.2 EUR |
|
Description: Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells. |
|||
Rosiglitazone HCl |
|||
| A4310-200 | ApexBio | 200 mg | 212.4 EUR |
|
Description: Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells. |
|||
Rosiglitazone HCl |
|||
| A4310-25 | ApexBio | 25 mg | 129.6 EUR |
|
Description: Rosiglitazone is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells. |
|||
Pioglitazone HCl |
|||
| A4324-10 | ApexBio | 10 mg | 142.8 EUR |
|
Description: Pioglitazone HCl is a potent and highly selective agonist of PPAR? with IC50 value of 3?M[1].Pioglitazone HCl can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue. |
|||
Pioglitazone HCl |
|||
| A4324-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Pioglitazone HCl is a potent and highly selective agonist of PPAR? with IC50 value of 3?M[1].Pioglitazone HCl can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue. |
|||
Pioglitazone HCl |
|||
| A4324-50 | ApexBio | 50 mg | 199.2 EUR |
|
Description: Pioglitazone HCl is a potent and highly selective agonist of PPAR? with IC50 value of 3?M[1].Pioglitazone HCl can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue. |
|||
Anagrelide HCl |
|||
| A4352-10 | ApexBio | 10 mg | 122.4 EUR |
|
Description: Anagrelide is a selective thrombocytopenic agent [1].Anagrelide is a FDA-approved drug for the treatment of essential thrombocythemia. It is originally identified as a potential inhibitor of platelet aggregation. |
|||
Anagrelide HCl |
|||
| A4352-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Anagrelide is a selective thrombocytopenic agent [1].Anagrelide is a FDA-approved drug for the treatment of essential thrombocythemia. It is originally identified as a potential inhibitor of platelet aggregation. |
|||
Anagrelide HCl |
|||
| A4352-50 | ApexBio | 50 mg | 282 EUR |
|
Description: Anagrelide is a selective thrombocytopenic agent [1].Anagrelide is a FDA-approved drug for the treatment of essential thrombocythemia. It is originally identified as a potential inhibitor of platelet aggregation. |
|||
Dorzolamide HCl |
|||
| A4357-10 | ApexBio | 10 mg | 153.6 EUR |
|
Description: Dorzolamide HCl is a carbonic anhydrase inhibitor. |
|||
Dorzolamide HCl |
|||
| A4357-100 | ApexBio | 100 mg | 522 EUR |
|
Description: Dorzolamide HCl is a carbonic anhydrase inhibitor. |
|||
Dorzolamide HCl |
|||
| A4357-25 | ApexBio | 25 mg | 205.2 EUR |
|
Description: Dorzolamide HCl is a carbonic anhydrase inhibitor. |
|||
Dorzolamide HCl |
|||
| A4357-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Dorzolamide HCl is a carbonic anhydrase inhibitor. |
|||
Dorzolamide HCl |
|||
| A4357-50 | ApexBio | 50 mg | 338.4 EUR |
|
Description: Dorzolamide HCl is a carbonic anhydrase inhibitor. |
|||
Tetracyclin Hcl |
|||
| abx082256-5g | Abbexa | 5 g | 226.8 EUR |
Guanidine Hcl |
|||
| abx082517-500g | Abbexa | 500 g | 226.8 EUR |
Tris-Hcl |
|||
| 20-abx082568 | Abbexa |
|
|
Tetracyclin Hcl |
|||
| abx082590-5g | Abbexa | 5 g | 210 EUR |
EDC-HCl |
|||
| 20-abx095087 | Abbexa |
|
|
Verapamil HCl |
|||
| 20-abx076503 | Abbexa |
|
|
Duloxetine HCl |
|||
| 20-abx076532 | Abbexa |
|
|
Puromycin HCl |
|||
| 20-abx076662 | Abbexa |
|
|
Nicardipine HCl |
|||
| 20-abx076668 | Abbexa |
|
|
Ambroxol HCl |
|||
| 20-abx076696 | Abbexa |
|
|
Irinotecan HCl |
|||
| 20-abx076771 | Abbexa |
|
|
Thioridazine HCl |
|||
| A8537-1000 | ApexBio | 1 g | 226.8 EUR |
|
Description: Thioridazine·HCl is a calcium channel protein inhibitor as well as D2DR/D4DR inhibitor. Its administration has been associated with hypotension. It has also been, after chronic treatment, used to test increased sensitivity of dopaminergic agents. |
|||
Thioridazine HCl |
|||
| A8537-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: Thioridazine·HCl is a calcium channel protein inhibitor as well as D2DR/D4DR inhibitor. Its administration has been associated with hypotension. It has also been, after chronic treatment, used to test increased sensitivity of dopaminergic agents. |
|||
Thioridazine HCl |
|||
| A8537-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Thioridazine·HCl is a calcium channel protein inhibitor as well as D2DR/D4DR inhibitor. Its administration has been associated with hypotension. It has also been, after chronic treatment, used to test increased sensitivity of dopaminergic agents. |
|||
Ondansetron HCl |
|||
| A5166-10 | ApexBio | 10 mg | 129.6 EUR |
|
Description: Ondansetron hydrochloride dihydrate is a serotonin-3 (5-HT3) receptor antagonist. |
|||
Ondansetron HCl |
|||
| A5166-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 157.2 EUR |
|
Description: Ondansetron hydrochloride dihydrate is a serotonin-3 (5-HT3) receptor antagonist. |
|||
Ondansetron HCl |
|||
| A5166-50 | ApexBio | 50 mg | 177.6 EUR |
|
Description: Ondansetron hydrochloride dihydrate is a serotonin-3 (5-HT3) receptor antagonist. |
|||
Alfuzosin HCl |
|||
| A5173-100 | ApexBio | 100 mg | 477.6 EUR |
|
Description: Functionally uro-selective ?1 adrenoceptor antagonist that does not discriminate between ?1 subtypes. Inhibits increases in intraurethral pressure caused by phenylephrine-induced contraction by 81% with minor cardiovascula |
|||
Alfuzosin HCl |
|||
| A5173-25 | ApexBio | 25 mg | 199.2 EUR |
|
Description: Functionally uro-selective ?1 adrenoceptor antagonist that does not discriminate between ?1 subtypes. Inhibits increases in intraurethral pressure caused by phenylephrine-induced contraction by 81% with minor cardiovascula |
|||
Alfuzosin HCl |
|||
| A5173-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: Functionally uro-selective ?1 adrenoceptor antagonist that does not discriminate between ?1 subtypes. Inhibits increases in intraurethral pressure caused by phenylephrine-induced contraction by 81% with minor cardiovascula |
|||
Alfuzosin HCl |
|||
| A5173-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 186 EUR |
|
Description: Functionally uro-selective ?1 adrenoceptor antagonist that does not discriminate between ?1 subtypes. Inhibits increases in intraurethral pressure caused by phenylephrine-induced contraction by 81% with minor cardiovascula |
|||
Arbidol HCl |
|||
| A8362-10 | ApexBio | 10 mg | 129.6 EUR |
|
Description: Arbidol (Umifenovir) hydrochloride is an broad-spectrum antiviral chemical agent which can inhibit cell entry of enveloped viruses by blocking viral fusion with host cell membrane. |
|||
Arbidol HCl |
|||
| A8362-100 | ApexBio | 100 mg | 421.2 EUR |
|
Description: Arbidol (Umifenovir) hydrochloride is an broad-spectrum antiviral chemical agent which can inhibit cell entry of enveloped viruses by blocking viral fusion with host cell membrane. |
|||
Arbidol HCl |
|||
| A8362-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Arbidol (Umifenovir) hydrochloride is an broad-spectrum antiviral chemical agent which can inhibit cell entry of enveloped viruses by blocking viral fusion with host cell membrane. |
|||
Conivaptan HCl |
|||
| A8402-10 | ApexBio | 10 mg | 166.8 EUR |
|
Description: Conivaptan Hydrochloride is a non-peptide inhibitor of antidiuretic hormone. Conivaptan Hydrochloride is used for treatment of congestive heart failure. |
|||
Conivaptan HCl |
|||
| A8402-100 | ApexBio | 100 mg | 808.8 EUR |
|
Description: Conivaptan Hydrochloride is a non-peptide inhibitor of antidiuretic hormone. Conivaptan Hydrochloride is used for treatment of congestive heart failure. |
|||
Conivaptan HCl |
|||
| A8402-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 181.2 EUR |
|
Description: Conivaptan Hydrochloride is a non-peptide inhibitor of antidiuretic hormone. Conivaptan Hydrochloride is used for treatment of congestive heart failure. |
|||
Dicyclomine HCl |
|||
| A8409-1000 | ApexBio | 1 g | 517.2 EUR |
|
Description: Used as a gastrointestinal antispasmodic antacid. |
|||
Dicyclomine HCl |
|||
| A8409-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Used as a gastrointestinal antispasmodic antacid. |
|||
Dicyclomine HCl |
|||
| A8409-5000 | ApexBio | 5 g | 1198.8 EUR |
|
Description: Used as a gastrointestinal antispasmodic antacid. |
|||
Difloxacin HCl |
|||
| A8411-1000 | ApexBio | 1 g | 142.8 EUR |
|
Description: Difloxacin HCl is a quinolone antimicrobial antibiotic [1]. Quinolone antibiotics target bacterial DNA gyrase which is required during DNA replication, subsequent DNA synthesis and ultimately cell division. |
|||
Difloxacin HCl |
|||
| A8411-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Difloxacin HCl is a quinolone antimicrobial antibiotic [1]. Quinolone antibiotics target bacterial DNA gyrase which is required during DNA replication, subsequent DNA synthesis and ultimately cell division. |
|||
Difloxacin HCl |
|||
| A8411-5000 | ApexBio | 5 g | 301.2 EUR |
|
Description: Difloxacin HCl is a quinolone antimicrobial antibiotic [1]. Quinolone antibiotics target bacterial DNA gyrase which is required during DNA replication, subsequent DNA synthesis and ultimately cell division. |
|||
Diperodon HCl |
|||
| A8413-100 | ApexBio | 100 mg | 129.6 EUR |
|
Description: Diperodon HCl |
|||
Diperodon HCl |
|||
| A8413-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Diperodon HCl |
|||
Diphenylpyraline HCl |
|||
| A8415-1000 | ApexBio | 1 g | 517.2 EUR |
|
Description: Diphenylpyraline is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. |
|||
Diphenylpyraline HCl |
|||
| A8415-10000 | ApexBio | 10 g | 1783.2 EUR |
|
Description: Diphenylpyraline is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. |
|||
Diphenylpyraline HCl |
|||
| A8415-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Diphenylpyraline is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. |
|||
Diphenylpyraline HCl |
|||
| A8415-5000 | ApexBio | 5 g | 1198.8 EUR |
|
Description: Diphenylpyraline is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class. |
|||
Doxapram HCl |
|||
| A8419-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 170.4 EUR |
|
Description: Doxapram HCl is a respiratory stimulant. |
|||
Doxapram HCl |
|||
| A8419-50 | ApexBio | 50 mg | 157.2 EUR |
|
Description: Doxapram HCl is a respiratory stimulant. |
|||
Doxycycline HCl |
|||
| A8420-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Doxycycline Hydrochloride is a synthetic tetracycline derivative with similar antimicrobial activity.Doxycycline is a tetracycline antibiotic which is commonly used to treat a variety of infections. Doxycycline treatment resulted in a 96% loss of Wolbachi |
|||
Doxycycline HCl |
|||
| A8420-50 | ApexBio | 50 mg | 157.2 EUR |
|
Description: Doxycycline Hydrochloride is a synthetic tetracycline derivative with similar antimicrobial activity.Doxycycline is a tetracycline antibiotic which is commonly used to treat a variety of infections. Doxycycline treatment resulted in a 96% loss of Wolbachi |
|||
Duloxetine HCl |
|||
| A8421-10 | ApexBio | 10 mg | 166.8 EUR |
|
Description: Duloxetine HCl is a selective serotonin and norepinephrine reuptake inhibitor . |
|||
Duloxetine HCl |
|||
| A8421-100 | ApexBio | 100 mg | 808.8 EUR |
|
Description: Duloxetine HCl is a selective serotonin and norepinephrine reuptake inhibitor . |
|||
Duloxetine HCl |
|||
| A8421-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Duloxetine HCl is a selective serotonin and norepinephrine reuptake inhibitor . |
|||
Ethambutol HCl |
|||
| A8427-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 135.6 EUR |
|
Description: Nocodazole is a tubulin production inhibitor, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 value of 0.21 ?M, 0.53 ?M and 0.64 ?M, respectively [1].Nocodazole is an inhibitor of microtubule polymerization which inhibits insulin-stimulated glucose transport. |
|||
Ethambutol HCl |
|||
| A8427-50 | ApexBio | 50 mg | 157.2 EUR |
|
Description: Nocodazole is a tubulin production inhibitor, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 value of 0.21 ?M, 0.53 ?M and 0.64 ?M, respectively [1].Nocodazole is an inhibitor of microtubule polymerization which inhibits insulin-stimulated glucose transport. |
|||
GW3965 HCl |
|||
| A8444-10 | ApexBio | 10 mg | 205.2 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
GW3965 HCl |
|||
| A8444-5 | ApexBio | 5 mg | 154.8 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
GW3965 HCl |
|||
| A8444-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 199.2 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
GW3965 HCl |
|||
| A8444-50 | ApexBio | 50 mg | 614.4 EUR |
|
Description: GW3965 HCl is a selective, orally active non-steroidal agonist for the liver X receptor (LXR) [1].Nuclear receptors LXR? and LXR? have an important role in control of cholesterol and fatty acid metabolism in multiple cell types. |
|||
Imidapril HCl |
|||
| A8447-10 | ApexBio | 10 mg | 129.6 EUR |
|
Description: Imidapril (INN) is an ACE inhibitor used as an antihypertensive drug and for the treatment of chronic heart failure. |
|||
Imidapril HCl |
|||
| A8447-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 151.2 EUR |
|
Description: Imidapril (INN) is an ACE inhibitor used as an antihypertensive drug and for the treatment of chronic heart failure. |
|||
Imidapril HCl |
|||
| A8447-50 | ApexBio | 50 mg | 274.8 EUR |
|
Description: Imidapril (INN) is an ACE inhibitor used as an antihypertensive drug and for the treatment of chronic heart failure. |
|||
Noscapine HCl |
|||
| A8479-1000 | ApexBio | 1 g | 517.2 EUR |
|
Description: Noscapine hydrochloride is the hydrochloride form of Noscapine. Noscapine is an opioid alkaloid with several actions. Antagonist at Bradykinin B Receptor (bradykinin receptors) , inhibits carbachol-stimulated phosphoinositol turnover and enhances forskolin-stimulated cAMP increases in CNS tissues. |
|||
Noscapine HCl |
|||
| A8479-10000 | ApexBio | 10 g | 1783.2 EUR |
|
Description: Noscapine hydrochloride is the hydrochloride form of Noscapine. Noscapine is an opioid alkaloid with several actions. Antagonist at Bradykinin B Receptor (bradykinin receptors) , inhibits carbachol-stimulated phosphoinositol turnover and enhances forskolin-stimulated cAMP increases in CNS tissues. |
|||
Noscapine HCl |
|||
| A8479-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Noscapine hydrochloride is the hydrochloride form of Noscapine. Noscapine is an opioid alkaloid with several actions. Antagonist at Bradykinin B Receptor (bradykinin receptors) , inhibits carbachol-stimulated phosphoinositol turnover and enhances forskolin-stimulated cAMP increases in CNS tissues. |
|||
Noscapine HCl |
|||
| A8479-5000 | ApexBio | 5 g | 1198.8 EUR |
|
Description: Noscapine hydrochloride is the hydrochloride form of Noscapine. Noscapine is an opioid alkaloid with several actions. Antagonist at Bradykinin B Receptor (bradykinin receptors) , inhibits carbachol-stimulated phosphoinositol turnover and enhances forskolin-stimulated cAMP increases in CNS tissues. |
|||
Mianserin HCl |
|||
| A1796-100 | ApexBio | 100 mg | 338.4 EUR |
|
Description: Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant. |
|||
Mianserin HCl |
|||
| A1796-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant. |
|||
Mianserin HCl |
|||
| A1796-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 151.2 EUR |
|
Description: Non-selective 5-HT2 receptor antagonist. Has moderate affinity for 5-HT6. Antidepressant. |
|||
Bendamustine HCl |
|||
| A1984-10 | ApexBio | 10 mg | 199.2 EUR |
|
Description: Bendamustine HCl is an alkylating agent associated with DNA damage with IC50 of 50 ?M [1]. It has been reported that bendamustine is activated under DNA damage stress and apoptosis. |
|||
Bendamustine HCl |
|||
| A1984-5 | ApexBio | 5 mg | 129.6 EUR |
|
Description: Bendamustine HCl is an alkylating agent associated with DNA damage with IC50 of 50 ?M [1]. It has been reported that bendamustine is activated under DNA damage stress and apoptosis. |
|||
Bendamustine HCl |
|||
| A1984-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 184.8 EUR |
|
Description: Bendamustine HCl is an alkylating agent associated with DNA damage with IC50 of 50 ?M [1]. It has been reported that bendamustine is activated under DNA damage stress and apoptosis. |
|||
Cyclobenzaprine HCl |
|||
| 20-abx180713 | Abbexa |
|
|
Tamsulosin HCl |
|||
| 20-abx180875 | Abbexa |
|
|
Decloxizini HCl |
|||
| 20-abx181258 | Abbexa |
|
|
Meclofenoxate HCl |
|||
| abx181309-100g | Abbexa | 100 g | 427.2 EUR |
Cyclopentanemethylamine HCl |
|||
| 20-abx182408 | Abbexa |
|
|
Antazoline HCl |
|||
| abx183853-25g | Abbexa | 25 g | 343.2 EUR |
Benzydamine HCl |
|||
| abx183874-10g | Abbexa | 10 g | 493.2 EUR |
Ciprofloxacin HCl |
|||
| 20-abx183943 | Abbexa |
|
|
Doxepin HCl |
|||
| 20-abx184015 | Abbexa |
|
|
Doxorubicin HCl |
|||
| 20-abx184016 | Abbexa |
|
|
Doxycycline HCl |
|||
| 20-abx184017 | Abbexa |
|
|
Isoprenaline HCl |
|||
| 20-abx184138 | Abbexa |
|
|
Octopamine HCl |
|||
| 20-abx184289 | Abbexa |
|
|
Pd128907 Hcl |
|||
| 20-abx184299 | Abbexa |
|
|
Propranolol HCl |
|||
| abx184325-1g | Abbexa | 1 g | 226.8 EUR |
Terbinafine HCl |
|||
| 20-abx184395 | Abbexa |
|
|
Atomoxetine HCl |
|||
| 20-abx184648 | Abbexa |
|
|
Procaine HCl |
|||
| 20-abx184762 | Abbexa |
|
|
Thiamine HCl |
|||
| 20-abx184786 | Abbexa |
|
|
Ambroxol Hcl |
|||
| abx188586-250g | Abbexa | 250 g | 309.6 EUR |
Minocycline Hcl |
|||
| abx188790-10g | Abbexa | 10 g | 927.6 EUR |
Naphazoline Hcl |
|||
| abx188809-1000g | Abbexa | 1000 g | 2064 EUR |
Prazosin HCl |
|||
| 20-abx185996 | Abbexa |
|
|
Tetracycline HCl |
|||
| 20-abx186579 | Abbexa |
|
|
Methylamine HCl |
|||
| abx187854-100g | Abbexa | 100 g | 444 EUR |
Chlorhexidine HCl |
|||
| abx187869-1kg | Abbexa | 1 kg | 1045.2 EUR |
LP533401 hcl |
|||
| B5823-25 | ApexBio | 25 mg | 1312.8 EUR |
|
Description: LP533401 hcl is an inhibitor of Tph-1 [1]. Tryptophan hydroxylase-1 (Tph-1) is an isoenzyme of tryptophan hydroxylase and the initial enzyme in gut- and lung-derived serotonin biosynthesis. Tph-1 is mainly expressed in the gut and lung [2]. |
|||
LP533401 hcl |
|||
| B5823-5 | ApexBio | 5 mg | 547.2 EUR |
|
Description: LP533401 hcl is an inhibitor of Tph-1 [1]. Tryptophan hydroxylase-1 (Tph-1) is an isoenzyme of tryptophan hydroxylase and the initial enzyme in gut- and lung-derived serotonin biosynthesis. Tph-1 is mainly expressed in the gut and lung [2]. |
|||
LX7101 HCL |
|||
| B5863-10 | ApexBio | 10 mg | 927.6 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-100 | ApexBio | 100 mg | 4837.2 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-5 | ApexBio | 5 mg | 582 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 576 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
LX7101 HCL |
|||
| B5863-50 | ApexBio | 50 mg | 3099.6 EUR |
|
Description: Description:IC50: 4.3, 32, 69 and 32 nM for LIMK2, KIMK1, ROCK1 and ROCK2, respectivleyLIM-kinases 1 and 2 (LIMK1 and LIMK2) regulate cytoskeletal dynamics by phosphorylating and deactivating cofilin, a protein that depolymerizes actin filaments. |
|||
SCH772984 HCl |
|||
| B5866-10 | ApexBio | 10 mg | 309.6 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-25 | ApexBio | 25 mg | 560.4 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 574.8 EUR |
|
Description: SCH772984 HCl |
|||
SCH772984 HCl |
|||
| B5866-50 | ApexBio | 50 mg | 950.4 EUR |
|
Description: SCH772984 HCl |
|||
Carteolol HCl |
|||
| B5944-100 | ApexBio | 100 mg | 1034.4 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Carteolol HCl |
|||
| B5944-25 | ApexBio | 25 mg | 547.2 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Carteolol HCl |
|||
| B5944-5 | ApexBio | 5 mg | 254.4 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Carteolol HCl |
|||
| B5944-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 268.8 EUR |
|
Description: Beta-adrenergic antagonist are an important class of drugs for the treatment of various heart diseases, such as high blood pressure, insufficiency of blood flow to the heart muscle, irregular heart beat, thickened heart muscle, and decreased ability of the heart to empty or fill normally. |
|||
Cyclobenzaprine HCl |
|||
| B5994-1000 | ApexBio | 1 g | 157.2 EUR |
|
Description: Cyclobenzaprine is a 5-HT2 receptor antagonist and inhibitor, in some article, cyclobenzaprine hydrochloride was used as the compound to research in cyclobenzaprine. |
|||
Cyclobenzaprine HCl |
|||
| B5994-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Cyclobenzaprine is a 5-HT2 receptor antagonist and inhibitor, in some article, cyclobenzaprine hydrochloride was used as the compound to research in cyclobenzaprine. |
|||
Cyclobenzaprine HCl |
|||
| B5994-5000 | ApexBio | 5 g | 448.8 EUR |
|
Description: Cyclobenzaprine is a 5-HT2 receptor antagonist and inhibitor, in some article, cyclobenzaprine hydrochloride was used as the compound to research in cyclobenzaprine. |
|||
SKF38393 HCl |
|||
| B6030-100 | ApexBio | 100 mg | 192 EUR |
|
Description: SKF38393 HCl (SKF38393) is a selective dopamine D1 receptor agonist [1], with an IC50 value of 110 nM [2].There are two functional types of dopamine receptors, D1 and D2 receptors [3]. The stimulation of the D1 receptor (D1R) in prefrontal cortex (PFC) results in an ?inverted-U? dose-response. |
|||
SKF38393 HCl |
|||
| B6030-200 | ApexBio | 200 mg | 282 EUR |
|
Description: SKF38393 HCl (SKF38393) is a selective dopamine D1 receptor agonist [1], with an IC50 value of 110 nM [2].There are two functional types of dopamine receptors, D1 and D2 receptors [3]. The stimulation of the D1 receptor (D1R) in prefrontal cortex (PFC) results in an ?inverted-U? dose-response. |
|||
SKF38393 HCl |
|||
| B6030-500 | ApexBio | 500 mg | 547.2 EUR |
|
Description: SKF38393 HCl (SKF38393) is a selective dopamine D1 receptor agonist [1], with an IC50 value of 110 nM [2].There are two functional types of dopamine receptors, D1 and D2 receptors [3]. The stimulation of the D1 receptor (D1R) in prefrontal cortex (PFC) results in an ?inverted-U? dose-response. |
|||
Tedizolid HCl |
|||
| B6049-10 | ApexBio | 10 mg | 309.6 EUR |
|
Description: IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM.Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. |
|||
Tedizolid HCl |
|||
| B6049-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM.Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. |
|||
Tedizolid HCl |
|||
| B6049-50 | ApexBio | 50 mg | 783.6 EUR |
|
Description: IC50: for MAO-A (monoamine oxidase-A), 8.7 uM; for MAO-B, 5.7 uM.Tedizolid HCl is a reversible, novel oxazolidinone antibiotic. It is the first oxazolidinone to be approved since linezolid in 2000. |
|||
Epinephrine HCl |
|||
| B1327-200 | ApexBio | 200 mg | 224.4 EUR |
|
Description: Epinephrine HCl is a hormone and a neurotransmitter. |
|||
Epinephrine HCl |
|||
| B1327-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Epinephrine HCl is a hormone and a neurotransmitter. |
|||
Epinephrine HCl |
|||
| B1327-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Epinephrine HCl is a hormone and a neurotransmitter. |
|||
Tolazoline HCl |
|||
| B1329-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Tolazoline is a non-selective competitive ?-adrenergic receptor antagonist. |
|||
Tolazoline HCl |
|||
| B1329-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Tolazoline is a non-selective competitive ?-adrenergic receptor antagonist. |
|||
Acebutolol HCl |
|||
| B1330-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Acebutolol is a ?-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. |
|||
Acebutolol HCl |
|||
| B1330-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Acebutolol is a ?-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. |
|||
Acebutolol HCl |
|||
| B1330-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Acebutolol is a ?-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias. |
|||
Adrenalone HCl |
|||
| B1331-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Adrenalone is an adrenergic agonist used as a topical vasoconstrictor and hemostatic, mainly acts on alpha-1 adrenergic receptors. |
|||
Adrenalone HCl |
|||
| B1331-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Adrenalone is an adrenergic agonist used as a topical vasoconstrictor and hemostatic, mainly acts on alpha-1 adrenergic receptors. |
|||
Adrenalone HCl |
|||
| B1331-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Adrenalone is an adrenergic agonist used as a topical vasoconstrictor and hemostatic, mainly acts on alpha-1 adrenergic receptors. |
|||
Clonidine HCl |
|||
| B1333-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Clonidine Hydrochloride is a centrally acting alpha-agonist hypotensive agent. |
|||
Clonidine HCl |
|||
| B1333-50 | ApexBio | 50 mg | 153.6 EUR |
|
Description: Clonidine Hydrochloride is a centrally acting alpha-agonist hypotensive agent. |
|||
Clonidine HCl |
|||
| B1333-S | ApexBio | Evaluation Sample | 97.2 EUR |
|
Description: Clonidine Hydrochloride is a centrally acting alpha-agonist hypotensive agent. |
|||
Isoprenaline HCl |
|||
| B1336-100000 | ApexBio | 100 g | 408 EUR |
|
Description: Isoprenaline HCl is an agonist of ?-adrenergic receptor [1].The adrenergic receptors are a class of G protein-coupled receptors that are targets of norepinephrine and epinephrine. |
|||
Isoprenaline HCl |
|||
| B1336-25000 | ApexBio | 25 g | 205.2 EUR |
|
Description: Isoprenaline HCl is an agonist of ?-adrenergic receptor [1].The adrenergic receptors are a class of G protein-coupled receptors that are targets of norepinephrine and epinephrine. |
|||
Isoprenaline HCl |
|||
| B1336-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Isoprenaline HCl is an agonist of ?-adrenergic receptor [1].The adrenergic receptors are a class of G protein-coupled receptors that are targets of norepinephrine and epinephrine. |
|||
Maprotiline HCl |
|||
| B1338-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 129.6 EUR |
|
Description: Maprotiline HCl |
|||
Moreover, a number of different compounds are recognized (e.g., ethanol) that correlate with inhabitants density and originate from a number of VCP sources. Ethanol and fragrances are amongst the most considerable and reactive VOCs related to VCP emissions.